By Charles Grob — 1996
On November 26, 1996, Charles Grob, M.D. visited with Albert Hofmann in Rheinfelden, outside of Basel, Switzerland, where Dr. Hofmann was recovering from knee surgery. The following are excerpts from their conversation.
Read on maps.org
CLEAR ALL
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
1
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2
It seems amazing that something so totally personal as ones level of consciousness could be considered an illegal act. But there is a turning of the tide both in policy and in scientific research, which has begun to recognise the value of these substances.
This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.
Sustainability leaders could learn from Zen master Thich Nhat Hanh, who believes in a deeper human connection with nature and looking beyond purely material consumption.